Previous 10 | Next 10 |
Carlsbad, CA, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that it had made equity grants to two new employees ...
CARLSBAD, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that Tom Hallam, Ph.D., Chief Executive Officer of Palisade B...
Palisade Bio ( NASDAQ: PALI ) is undergoing a program to streamline operations that includes focusing on lead clinical program LB1148 and laying off 20% of its staff. The gastrointestinal-focused biotech said it is implementing cost-savings measures of more t...
CARLSBAD, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that following an internal strategic review, the Management T...
CARLSBAD, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal (GI) complications, today announced that Tom Hallam, Ph.D., Chief Executive Officer and Michael D...
Which penny stocks are at the top of your list today? If you’ve seen some of the biggest gapping stocks of the day, you’ll see several that we’ve discussed right here on PennyStocks.com have exploded over the last few sessions. Companies like Bright Minds Biosciences ( ...
The following slide deck was published by Palisade Bio, Inc. in conjunction with this event. For further details see: Palisade Bio (PALI) Investor Presentation - Slideshow
Palisade Bio ( NASDAQ: PALI ) was downgraded by Maxim Group to Hold from Buy citing additional dilution and need for additional funding for clinical programs. The SA Quant Rating on PALI is Hold , which takes into account factors such as growth and profitability, among o...
3 Hot Penny Stocks to Watch During Trading Today With penny stocks and blue chips showing a great deal of volatility, buying and selling stocks right now is not easy. Over the past few weeks, we’ve seen the stock market go from overly bullish to mostly flat, and everything in bet...
3 Cheap Penny Stocks to Watch in August 2022 If you’re looking for penny stocks to buy right now, there are a few things you should keep in mind. For one, right now, there is a lot of volatility in the stock market. This means that stocks are going up and down in valu...
News, Short Squeeze, Breakout and More Instantly...
Patent includes Composition of Matter claims for both PALI-2108 and PALI-1908 programs Patent includes broad claims for “Gut Microbiota Bioactivated PDE4 Inhibitor Precursors” with similar structure to PALI-2108 and PALI-1908 This patent family provides Composition o...
Company has now completed murine and non-murine pivotal nonclinical studies using GMP PALI-2108 drug substance Company has successfully formulated enteric-coated tablets of PALI-2108 and has demonstrated consistent and reliable drug release profiles Company on track to commence Ph...
Live video webcast on Wednesday, June 26 th at 4:00 PM ET Carlsbad, CA, June 24, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), biopharmaceutical company focused on developing and advancing novel...